Nano-Bio Innovation Seminar

When: Wednesday, February 27, 2013 at 4:40 pm
Where: SH 335
Speaker: Jonathan Fleming
Organization: Managing Partner, Oxford Biosciences Partners
Sponsor: IGERT Nanomedicine Science & Technology

Jonathan Fleming is the Managing Partner of Oxford Bioscience Partners, an international venture capital firm specializing in life science technology based investments, with offices in Boston, Massachusetts and Seoul, Korea. He is a General Partner of the Korea-Seoul Life Science Fund.

Mr. Fleming has been in the investment business for over twenty seven years, starting and financing growth companies in the United States, Europe, Israel and Asia. Prior to joining OBP in 1996, he was a Founding General Partner of MVP Ventures in Boston, MA. He began his investment career with TVM Techno Venture Management in Munich, Germany. Mr. Fleming has also co-founded Medica Venture Partners, a venture capital investment firm specializing in early stage healthcare and biotechnology companies started in Israel. Mr. Fleming is a director of several private companies including Dicerna Pharmaceuticals, Lab Partners, Radius Pharmaceuticals, Greenlight and Railrunner. He is also a director of Leerink Swann, a Boston based investment bank specializing in healthcare companies. In addition, Mr. Fleming is a Senior Lecturer at the MIT Sloan School of Business, a member of the Board of NEHI, a healthcare oriented think tank and policy advocacy group. Mr. Fleming is on the Scientific Advisory Board of the Massachusetts Life Science Center and is a member of the Chancellors Commercialization Advisory Board of the University of Texas System. Mr. Fleming holds a Master’s degree in Public Administration from Princeton University and a Bachelor of Arts degree¬† from the University of California, Berkeley.